Annual EBIT
-$47.67 M
+$3.05 M+6.02%
31 December 2023
Summary:
Galera Therapeutics annual earnings before interest & taxes is currently -$47.67 million, with the most recent change of +$3.05 million (+6.02%) on 31 December 2023. During the last 3 years, it has risen by +$21.69 million (+31.27%). GRTX annual EBIT is now -101.31% below its all-time high of -$23.55 million.GRTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$4.06 M
+$317.00 K+7.24%
30 June 2024
Summary:
Galera Therapeutics quarterly earnings before interest & taxes is currently -$4.06 million, with the most recent change of +$317.00 thousand (+7.24%) on 30 June 2024. Over the past year, it has increased by +$8.92 million (+68.70%). GRTX quarterly EBIT is now at all-time high.GRTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$26.31 M
+$12.25 M+31.76%
30 June 2024
Summary:
Galera Therapeutics TTM earnings before interest & taxes is currently -$26.31 million, with the most recent change of +$12.25 million (+31.76%) on 30 June 2024. Over the past year, it has increased by +$29.41 million (+52.78%). GRTX TTM EBIT is now -396.38% below its all-time high of -$5.30 million, reached on 30 September 2018.GRTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.0% | +68.7% | +52.8% |
| 3 y3 years | +31.3% | +80.0% | +66.1% |
| 5 y5 years | -101.3% | +67.3% | +36.7% |
GRTX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +35.0% | at high | +80.0% | at high | +66.1% |
| 5 y | 5 years | -101.3% | +35.0% | at high | +80.7% | at high | +66.1% |
| alltime | all time | -101.3% | +35.0% | at high | +80.7% | -396.4% | +66.1% |
Galera Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$4.06 M(-7.2%) | -$26.31 M(-31.8%) |
| Mar 2024 | - | -$4.38 M(-10.3%) | -$38.56 M(-19.1%) |
| Dec 2023 | -$47.67 M(-6.0%) | -$4.88 M(-62.4%) | -$47.67 M(-14.5%) |
| Sept 2023 | - | -$12.99 M(-20.4%) | -$55.72 M(+0.4%) |
| June 2023 | - | -$16.31 M(+21.0%) | -$55.52 M(+8.7%) |
| Mar 2023 | - | -$13.49 M(+4.3%) | -$51.07 M(+0.7%) |
| Dec 2022 | -$50.72 M(-30.8%) | -$12.93 M(+1.1%) | -$50.72 M(-3.0%) |
| Sept 2022 | - | -$12.79 M(+7.8%) | -$52.28 M(-12.6%) |
| June 2022 | - | -$11.86 M(-9.7%) | -$59.79 M(-13.4%) |
| Mar 2022 | - | -$13.14 M(-9.3%) | -$69.02 M(-5.9%) |
| Dec 2021 | -$73.34 M | -$14.49 M(-28.6%) | -$73.34 M(-5.6%) |
| Sept 2021 | - | -$20.30 M(-3.7%) | -$77.67 M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$21.08 M(+20.7%) | -$73.22 M(+5.4%) |
| Mar 2021 | - | -$17.46 M(-7.3%) | -$69.49 M(+0.2%) |
| Dec 2020 | -$69.35 M(+41.8%) | -$18.83 M(+18.8%) | -$69.35 M(+4.7%) |
| Sept 2020 | - | -$15.84 M(-8.7%) | -$66.27 M(+5.4%) |
| June 2020 | - | -$17.36 M(+0.2%) | -$62.86 M(+11.6%) |
| Mar 2020 | - | -$17.32 M(+10.0%) | -$56.32 M(+15.2%) |
| Dec 2019 | -$48.91 M(+106.5%) | -$15.74 M(+26.6%) | -$48.91 M(+17.6%) |
| Sept 2019 | - | -$12.43 M(+14.9%) | -$41.59 M(+20.7%) |
| June 2019 | - | -$10.82 M(+9.2%) | -$34.46 M(+45.8%) |
| Mar 2019 | - | -$9.91 M(+17.6%) | -$23.64 M(+72.2%) |
| Dec 2018 | -$23.68 M(-0.9%) | -$8.43 M(+58.9%) | -$13.73 M(+158.9%) |
| Sept 2018 | - | -$5.30 M | -$5.30 M |
| Dec 2017 | -$23.91 M | - | - |
FAQ
- What is Galera Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Galera Therapeutics?
- What is Galera Therapeutics annual EBIT year-on-year change?
- What is Galera Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Galera Therapeutics?
- What is Galera Therapeutics quarterly EBIT year-on-year change?
- What is Galera Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Galera Therapeutics?
- What is Galera Therapeutics TTM EBIT year-on-year change?
What is Galera Therapeutics annual earnings before interest & taxes?
The current annual EBIT of GRTX is -$47.67 M
What is the all time high annual EBIT for Galera Therapeutics?
Galera Therapeutics all-time high annual earnings before interest & taxes is -$23.55 M
What is Galera Therapeutics annual EBIT year-on-year change?
Over the past year, GRTX annual earnings before interest & taxes has changed by +$3.05 M (+6.02%)
What is Galera Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of GRTX is -$4.06 M
What is the all time high quarterly EBIT for Galera Therapeutics?
Galera Therapeutics all-time high quarterly earnings before interest & taxes is -$4.06 M
What is Galera Therapeutics quarterly EBIT year-on-year change?
Over the past year, GRTX quarterly earnings before interest & taxes has changed by +$8.92 M (+68.70%)
What is Galera Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of GRTX is -$26.31 M
What is the all time high TTM EBIT for Galera Therapeutics?
Galera Therapeutics all-time high TTM earnings before interest & taxes is -$5.30 M
What is Galera Therapeutics TTM EBIT year-on-year change?
Over the past year, GRTX TTM earnings before interest & taxes has changed by +$29.41 M (+52.78%)